MacroGenics | Ativo Circulante

Current Assets Alterar Data
AbbVie USD 38.87B 5.65B 2024-03
Amgen USD 28.03B 2.3B 2024-03
AstraZeneca USD 25.59B 540M 2024-03
Biogen USD 6.76B 103.1M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Daiichi Sankyo JPY 2.12T 593.84B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
Genmab DKK 34.37B 1.23B 2024-03
Geron USD 451.51M 110.16M 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
J&J USD 57B 3.3B 2024-03
MacroGenics USD 202.58M 48.76M 2024-03
Merck USD 31.44B 509M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Xencor USD 562.25M 60.91M 2024-03



MacroGenics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.